Data Readout Anticipated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data readout anticipated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Readout Anticipated Today - Breaking & Trending Today

Yumanity Therapeutics : Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 Closed $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Form 8-K

Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors

Initial KVA12123 Clinical Data Readout Anticipated by End of 2023

. | May 11, 2023 ....

Myriam Chalabi , Michaela Curran , Patricia Lorusso , Shawn Iadonato , John Mullaly , Evany Yu , Jacques Bouchy , Lifesci Advisors , Kineta Inc , Netherlands Cancer Institute , Clinical Research Division , Fred Hutchinson Cancer Consortium , Investor Relations Business Development , Clinical Research , Fred Hutchinson Cancer Center , Dosed First Patient , Advanced Solid Tumors , Data Readout Anticipated , Registered Direct Offering Priced At The Market , Nasdaq Rules , Chief Executive Officer , Scientific Advisory Board , Section Head , Cancer Medicine , Medical Director , Key Opinion Leader Event ,